Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Post by NothinButTimeon Aug 16, 2020 2:32pm
585 Views
Post# 31414954

Hai Kang Life Affiliation To Sona Nanotech

Hai Kang Life Affiliation To Sona Nanotech

A little more about Hai Kang Life for those interested:

 

Professor Albert Cheung-Hoi Yu, PHD, is a renowned neuroscientist and bio-entrepreneur who has devoted over two decades in neuroscience and infectious disease research, and he has had significant contributions to molecular neurobiology and molecular diagnosis.  

 

Professor Yu is the Vice-Director of the Neuroscience Research Institute, Professor of the Department of Neurobiology and also a Professor at the Infectious Disease Center at Peking University. 

 

The professor is also the Director of the Asian Fund for Cancer Research and the Chairman of the Hong Kong Biotechnology Organization, and he agreed to talk to us about the tests that he and his team at Hai Kang have developed for SARS-CoV-2, a test he says is “the most sensitive in the world.”

https://markets.businessinsider.com/news/stocks/developer-of-pharmacyte-biotech-s-covid-19-test-explains-why-his-test-is-so-highly-sensitive-path-to-fda-eua-and-commercialization-1029107431

 

Hai Kang Life video explaining their EFAD Chip molecular technology and BioRadar system.

https://youtu.be/u3ykRdv6HeQ

 

Hai Kang Life received CE Mark for their RT-PCR test under licensee PharmaCyte Biotech (based out of California) on July 29, 2020.  Hai Kang is based out of Hing Kong.

https://www.genomeweb.com/regulatory-news-fda-approvals/hai-kang-life-gets-ce-mark-sars-cov-2-tests

 

Sona Nanotech is partnered with Hai Kang Life to develop a self administered, fingerstick antibody test, intended for home use.

 

https://cdn.ceo.ca.s3-us-west-2.amazonaws.com/1fjigru-AB0CF81B-F869-4A38-B55B-90CEEE70EFA1.png

<< Previous
Bullboard Posts
Next >>